Catalyst Wire Dossier Catalyst Wire Dossier

Ulixacaltamide

· Praxis Precision Medicines
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ulixacaltamide, covering 2025-09-30 to 2025-09-30. Get the full timeline:

Most recent: Clinical Trial Update: Essential 3 - Decentralized, Phase 3 Study Evaluating the Safety and Efficacy of Ulixacaltamide in Essential Tremor (ET) [Phase 3]

See pricing